🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
Most of patients with autoimmune encephalitis are left with permanent cogni...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-04-07
Trial ID
NCT03530462
Treatments Being Tested
Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Status
Completed
Location
Hospital Universitario Son Espases
Start Date
2016-04-07
Trial ID
NCT02692248
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
The purpose of this study is to evaluate biosimilarity between test product...
Status
Completed
Location
Clinical Centre Banja Luka Location Paprikovac
Start Date
2013-05
Trial ID
NCT02468791
Treatments Being Tested
This study will evaluate the safety and efficacy of the combination of ritu...
Status
Completed
Location
University Hospital Ghent
Start Date
2009-06
Trial ID
NCT00936546
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
This study will compare the plasma pharmacokinetic profile and the change i...
Status
Completed
Location
Gurunank Care Hospital
Start Date
2014-11
Trial ID
NCT02296775
This single arm study will evaluate the efficacy and safety of MabThera in ...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00462345
Treatments Being Tested
Immunological factors are assumed to be determinants for some psychiatric d...
Status
Active Not Recruiting
Location
Örebro university hospital
Start Date
2023-03-21
Trial ID
NCT05622201
Treatments Being Tested